Assistant Professor Khalid Hirmiz is a member of the Department of Oncology at Western University. His research focuses on radiation oncology, specifically investigating the use of image-guided radiotherapy for thoracic and gastrointestinal cancers. He evaluates the efficacy of novel radiation fractionation schedules in improving local tumor control and reducing treatment-related toxicity. His mission is to advance cancer care through the study of precise radiation delivery and clinical trial participation. Dr. Hirmiz provides clinical supervision for radiation oncology residents and fellows. He is dedicated to optimizing oncological outcomes through the implementation of personalized and evidence-based radiation treatments.